
Pulse Biosciences, Inc. Updates Investor Presentation

On November 13, 2025, Pulse Biosciences, Inc. released an updated investor presentation highlighting product development progress. Key Highlights: New details on nPulse Vybrance Percutaneous Electrode.Progress updates on nPulse Cardiac Clamp and Catheter.Presentation to be used in investor and analyst meetings.Available on the company's website for public access.Original SEC Filing: PULSE BIOSCIENCES, INC. [ PLSE ] - 8-K - Nov. 13, 2025DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
On November 13, 2025, Pulse Biosciences, Inc. released an updated investor presentation highlighting product development progress.
Key Highlights:
- New details on nPulse Vybrance Percutaneous Electrode.
- Progress updates on nPulse Cardiac Clamp and Catheter.
- Presentation to be used in investor and analyst meetings.
- Available on the company's website for public access.
Original SEC Filing: PULSE BIOSCIENCES, INC. [ PLSE ] - 8-K - Nov. 13, 2025

